Accepting new patients

Dr. Bahman Daneshfar, MD

Radiation Oncology ·  Male · Age 57

Dr. Daneshfar

Opelousas Community Cancer Center

627 E Prudhomme St Ste 1 Opelousas, LA 70570

Accepting new patients

Make an Appointment

(337) 942-1126


Dr. Bahman Daneshfar, MD is a radiation oncology specialist in Opelousas, LA and has been practicing for 26 years. He graduated from University Of Missouri--Columbia School Of Medicine in 1988 and specializes in radiation oncology.


At a glance

  • Explains conditions well . Patients said this doctor explains conditions well. See reviews
  • Hospital satisfaction . Patients said they were highly satisfied at this doctor's hospital. See hospitals
  • Good communication . Patients said there was good doctor communication at the hospital. See hospitals

Insurance Check

Search for your insurance provider

Dr. Daneshfar accepts most major insurance plans.

Dr. Daneshfar has indicated that he accepts most major insurance carriers

Accepted insurance can change. Please double-check when making an appointment.

(337) 942-1126Find providers who accept this insurance

Background Check

Healthgrades does not collect malpractice claims information for Louisiana
No disciplinary actions found for the years we collect data
No board actions found for the years we collect data
Learn more about background checks

Experience Check

Check Dr. Daneshfar's experience treating your condition or procedure

Dr. Daneshfar's Top Procedures and Conditions

Treatment Frequency
Cancer
normal
normal

Treatment Frequency

Dr. Daneshfar treats Cancer more than 67% of his peers

Dr. Daneshfar treats this condition more than 67% of his peers

Rating Includes other areas of care:

  • Adenoid Cystic Carcinoma
  • Adolescent Cancer
  • Adrenal Cortical Carcinoma
  • Adrenal Gland Cancer
  • Adult Cerebral Astrocytoma
  • Adult Small Cell Lung Cancer
  • Ampullary Carcinoma
  • Anal and Rectal Cancer
  • Anal Cancer
  • Anaplastic Oligodendroglioma
  • Angiosarcoma of the Breast
  • Appendix Cancer
  • Astrocytoma
  • Basal Cell Carcinoma (BCC)
  • Basal Type Breast Cancer
  • Benign Astrocytoma
  • Bile Duct Cancer
  • Biliary Cancer
  • Bladder Cancer
  • Blood Cancer
  • Bone Cancer
  • Brain and Nervous System Cancer (Includes: Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
  • Brain Cancer
  • Brainstem Glioma
  • Breast Cancer
  • Breast Cancer Recurrence
  • Bronchioalveolar Carcinoma
  • Bronchogenic Carcinoma
  • Cancer of Floor of Mouth
  • Cerebellar Astrocytoma
  • Cerebral Astrocytoma
  • Cervical Cancer
  • Cholangiocarcinoma
  • Chordoma
  • Choriocarcinoma
  • Chromophobe Renal Cell Carcinoma
  • Clear Cell Adenocarcinoma
  • Clear Cell Renal Cell Carcinoma
  • Colorectal Cancer
  • Cutaneous Squamous Cell Carcinoma
  • Distal Colorectal Cancer
  • Distal Gastrointestinal Tract Cancers
  • Ductal Carcinoma in Situ
  • Duodenal Cancer
  • Ear Cancer
  • Endocrine Cancer
  • Endometrial Cancer
  • ENT Cancer
  • Epidermoid Carcinoma
  • Epithelial-Myoepithelial Carcinoma
  • Esophageal Cancer
  • Extrahepatic Bile Duct Cancer
  • Eye Cancer
  • Facial Skin Cancer
  • Fallopian Tube Cancer
  • Familial Colorectal Cancer
  • Familial Pancreatic Cancer
  • Familial Renal Cancer
  • Familial Renal Cell Carcinoma
  • Fibrolamellar Hepatocellular Carcinoma
  • Follicular Adenocarcinoma
  • Follicular Thyroid Cancer
  • Gall Bladder Cancer
  • Gallbladder & Biliary Tract Cancer
  • Gastric Cancer, Borrmann 4
  • Gastroenterologic Cancer (Colon, Stomach, Esophageal, Liver)
  • Genital System Cancer
  • Genitourinary Cancers
  • Gland Cancer
  • Glassy Cell Carcinoma
  • Glioma
  • Gliomatosis Cerebri
  • Gynecologic Cancer
  • Hamartomatous Colorectal Cancer
  • Heart Cancer
  • Hepatobiliary Cancer
  • Hepatocellular Cancer
  • Hepatocellular Carcinoma
  • Hip Cancer
  • Hypopharyngeal Cancer
  • Inflammatory Breast Cancer
  • Infundibulocystic Basal Cell Carcinoma
  • Intestinal Cancer
  • Intrahepatic Cholangiocarcinoma
  • Invasive Breast Cancer
  • Invasive Ductal Carcinoma
  • Invasive Lobular Carcinoma
  • Joint Cancer
  • Juvenile Pilocytic Astrocytoma
  • Laryngeal Cancer
  • Laryngeal Carcinoma
  • Limb Cancer
  • Lip Cancer
  • Liver Cancer
  • Locally Advanced Breast Cancer
  • Lung Cancer
  • Lymphoma of the Breast
  • Male Breast Cancer
  • Male Genitourinary Cancer
  • Malignant Astrocytoma
  • Malignant Breast Tumor
  • Malignant Glioma
  • Mediastinal Cancer
  • Medullary Thyroid Cancer
  • Medulloblastoma
  • Melanoma-Astrocytoma Syndrome
  • Merkel Cell Cancer
  • Metastatic Adrenal Gland Cancer
  • Metastatic Blood Cancer
  • Metastatic Bone Cancer
  • Metastatic Breast Cancer
  • Metastatic Cancer
  • Metastatic Liver Cancer
  • Metastatic Lymph Cancer
  • Metastatic Nervous System Cancer
  • Metastatic Prostate Cancer
  • Metastatic Skin Cancer
  • Metastatic Soft Tissue Cancer
  • Metastatic Spinal Cord Cancer
  • Metastatic Squamous Neck Cancer With Occult Primary
  • MSI-H Colorectal Cancer
  • MSI-L Colorectal Cancer
  • MSS Colorectal Cancer
  • Muscle Cancer
  • Nasal Cavity Cancer
  • Nasopharyngeal Cancer
  • Neck Cancer
  • Nerve Cancer
  • Neuroendocrine Cancer
  • Nevoid Basal Cell Carcinoma Syndrome
  • Nodular Basal Cell Carcinoma
  • Noduloulcerative Basal Cell Carcinoma
  • Non-Melanoma Skin Cancer
  • Nonpolyposis Colorectal Cancer, Familial
  • Non-Small Cell Lung Cancer
  • Nose Cancer
  • Oligodendroglioma
  • Oral Cancer
  • Oral Squamous Cell Carcinoma
  • Oropharyngeal Cancer
  • Oropharyngeal Cancer, Adult
  • Osteosarcoma of the Breast
  • Ovarian Cancer
  • Ovarian Epithelial Cancer
  • Palate Cancer
  • Pancreatic Cancer
  • Pancreatic Islet Cell Cancer
  • Papillary Renal Cell Carcinoma
  • Papillary Thyroid Cancer
  • Paranasal Sinus Cancer
  • Parathyroid (Gland) Cancer
  • Parathyroid Carcinoma
  • Parotid Gland Cancer
  • Pediatric Cancer
  • Pelvic Cancer
  • Penile Cancer
  • Pharyngeal Cancer
  • Pigmented Basal Cell Carcinoma
  • Pleura Cancer
  • Pre-Invasive Breast Cancer
  • Primary Prostate Cancer
  • Prostate Cancer
  • Prostate Cancer - Hereditary - 1
  • Prostate Cancer - Hereditary - 10
  • Prostate Cancer - Hereditary - 11
  • Prostate Cancer - Hereditary - 14
  • Prostate Cancer - Hereditary - 2
  • Prostate Cancer - Hereditary - 3
  • Prostate Cancer - Hereditary - 4
  • Prostate Cancer - Hereditary - 5
  • Prostate Cancer - Hereditary - 6
  • Prostate Cancer - Hereditary - 7
  • Prostate Cancer - Hereditary - 8
  • Prostate Cancer - Hereditary - 9
  • Prostate Cancer - Hereditary - X-Linked 1
  • Prostate Cancer - Hereditary - X-Linked 2
  • Prostate Cancer - Hereditary -12
  • Prostate Cancer - Hereditary -13
  • Prostate Cancer - Hereditary -15
  • Radiation-Induced Angiosarcoma of the Breast
  • Rectal Cancer
  • Renal (Kidney) Cancer
  • Renal Cell Cancer
  • Respiratory System Cancer
  • Retinal Cancer
  • Salivary Gland Cancer
  • Sebaceous Gland Carcinoma
  • Secretory Breast Carcinoma
  • Sinonasal Undifferentiated Carcinoma
  • Sinus Cancer
  • Skin Cancer
  • Small Cell Lung Cancer
  • Spinal Cord Cancer
  • Spleen Cancer
  • Sporadic Colorectal Cancer
  • Squamous Cell Carcinoma
  • Squamous Cell Carcinoma of Conjunctiva
  • Squamous Cell Carcinoma of Head and Neck
  • Stomach and Small Intestine Cancer
  • Stomach Cancer
  • Stomach Cancer, Familial
  • Superficial Basal Cell Carcinoma
  • Supraglottic Laryngeal Cancer
  • Testicular Cancer
  • Thoracic Cancer
  • Throat Cancer
  • Thymus Cancer
  • Thyroid Cancer
  • Thyroid Cancer, Anaplastic
  • Thyroid Cancer, Familial Medullary
  • Thyroid Cancer, Hurthle Cell
  • Tongue Cancer
  • Trachea Cancer
  • Transitional Cell Cancer
  • Transitional Cell Carcinoma
  • Tubular Carcinoma
  • Urachal Cancer
  • Ureteral Cancer
  • Urinary Tract Cancer
  • Uterine Cancer
  • Vaginal Cancer
  • Visual Pathway and Hypothalamic Glioma
  • Vocal Cord Carcinoma
  • Vulvar Cancer
Thyroid Cancer
normal
normal

Treatment Frequency

Dr. Daneshfar treats Thyroid Cancer more than 5% of his peers

Dr. Daneshfar treats this condition more than 5% of his peers

Rating Includes other areas of care:

  • Follicular Adenocarcinoma
  • Follicular Thyroid Cancer
  • Medullary Thyroid Cancer
  • Papillary Thyroid Cancer
  • Parathyroid (Gland) Cancer
  • Thyroid Cancer, Anaplastic
  • Thyroid Cancer, Familial Medullary
  • Thyroid Cancer, Hurthle Cell
Prostate Cancer
normal
normal

Treatment Frequency

Dr. Daneshfar treats Prostate Cancer more than 5% of his peers

Dr. Daneshfar treats this condition more than 5% of his peers

Rating Includes other areas of care:

  • Primary Prostate Cancer
  • Prostate Cancer - Hereditary - 1
  • Prostate Cancer - Hereditary - 10
  • Prostate Cancer - Hereditary - 11
  • Prostate Cancer - Hereditary - 14
  • Prostate Cancer - Hereditary - 2
  • Prostate Cancer - Hereditary - 3
  • Prostate Cancer - Hereditary - 4
  • Prostate Cancer - Hereditary - 5
  • Prostate Cancer - Hereditary - 6
  • Prostate Cancer - Hereditary - 7
  • Prostate Cancer - Hereditary - 8
  • Prostate Cancer - Hereditary - 9
  • Prostate Cancer - Hereditary - X-Linked 1
  • Prostate Cancer - Hereditary - X-Linked 2
  • Prostate Cancer - Hereditary -12
  • Prostate Cancer - Hereditary -13
  • Prostate Cancer - Hereditary -15

Dr. Daneshfar's conditions and procedures:

  • 3D Conformal Radiotherapy
  • Adult Development Disorders
  • Anal Cancer
  • Bladder Cancer
  • Bone Cancer
  • Brachytherapy
  • Brain Cancer
  • Brain Tumor
  • Breast Cancer
  • Cancer
  • Cancer Counseling
  • Cancer Treatment Complications
  • Cervical Cancer
  • Colorectal Cancer
  • Endometrial Cancer
  • Esophageal Cancer
  • Gallbladder Cancer
  • Genitourinary Cancers
  • Goiter
  • Graves' Disease
  • Gynecologic Cancer
  • Hodgkin's Disease
  • Hyperthrophic Scar
  • Keloid Scar
  • Laryngeal Cancer
  • Liver Cancer
  • Liver Tumor
  • Lung Cancer
  • Lung Neoplasms, Not Specified as Malignant
  • Lymphoma
  • Malignant Neoplasm of Gastrointestinal Tract
  • Mediastinal Cancer
  • Melanoma
  • Neoplasm of Gastrointestinal Tract
  • Non-Hodgkin's Lymphoma
  • Pancreatic Cancer
  • Prostate Cancer
  • Rectal Cancer
  • Sarcoma
  • Skin Cancer
  • Spinal Cord Tumor
  • Stereotactic Radiosurgery
  • Stomach Cancer
  • Testicular Cancer
  • Throat Cancer
  • Throat Cancer (Hypopharyngeal)
  • Throat Cancer (Oropharyngeal)
  • Thyroid Cancer
  • Vaginal Cancer
  • Vulvar Cancer

Dr. Daneshfar's Reviews

Likelihood to recommend Dr. Daneshfar

4.9

Based on 9 reviews

5 Stars
88.88888888888889%
(8)
4 Stars
11.11111111111111%
(1)
3 Stars
0%
(0)
2 Stars
0%
(0)
1 Star
0%
(0)

Leave a review

How likely are you to recommend
Dr. Daneshfar?
(Select your rating)
Average Reported Wait Time
  • 10 – 15 minutes
Dr. Daneshfar's Performance
  • Trustworthiness
  • Explains condition(s) well
  • Answers questions
  • Time well spent
Office & Staff Performance
  • Scheduling
  • Office environment
  • Staff friendliness

Be the first to leave a comment

How was your experience with Dr. Daneshfar?

About Me

Care Philosophy

Unbiased care of the cancer patient. No affiliation or motivation by outside groups with special interest in profit. Take care of the cancer patient unconditionally.

Specialties

  • Radiation Oncology

Board Certifications

Education

1993
University Tex Med Br
Residency Hospital
1989
Deaconess Hospital
Internship Hospital
1988
University Of Missouri--Columbia School Of Medicine
Medical School
1984
Missouri State Univ
Undergraduate School
1993
1989
1988
1984

Languages

  • Farsi
  • English

Awards

  • Healthgrades Honor Roll
  • Outstanding Premed student, 1984
  • Top 20 student in Medical School, 1988
  • Summa Cum Laude top 1% Univ Missouri State, 1984

Affiliated Hospitals

Check the quality of care at hospitals where Dr. Daneshfar treats patients.

Learn more

81% Patient experience rating, 12% higher than the national average

  • Outstanding Patient Experience Award™ (2019, 2018, 2017)

62% Patient experience rating, 7% lower than the national average

79% Patient experience rating, 10% higher than the national average

  • Outstanding Patient Experience Award™ (2019, 2018, 2017)

89% Patient experience rating, 20% higher than the national average

  • Outstanding Patient Experience Award™ (2019, 2018, 2017)

73% Patient experience rating, 4% higher than the national average

  • Patient Safety Excellence Award™ (2017)

Compare Providers

More providers who are similar to Dr. Daneshfar


Opelousas, LA

>

Accepts 4 insurance plans


Opelousas, LA

>

Accepts 5 insurance plans


Baton Rouge, LA

>

Accepts 13 insurance plans


Opelousas, LA

>

Accepts 5 insurance plans


Baton Rouge, LA

>

Accepts 13 insurance plans


Covington, LA

>

Accepts 33 insurance plans